Omnicell Technologies (OMCL) Stake Lifted by King Luther Capital Management Corp

King Luther Capital Management Corp grew its holdings in Omnicell Technologies (NASDAQ:OMCL) by 5.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 75,315 shares of the company’s stock after purchasing an additional 3,960 shares during the quarter. King Luther Capital Management Corp’s holdings in Omnicell Technologies were worth $3,269,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also made changes to their positions in the company. Louisiana State Employees Retirement System lifted its stake in shares of Omnicell Technologies by 7.2% in the 4th quarter. Louisiana State Employees Retirement System now owns 16,300 shares of the company’s stock valued at $791,000 after purchasing an additional 1,100 shares during the period. Teachers Advisors LLC lifted its stake in shares of Omnicell Technologies by 1.3% in the 4th quarter. Teachers Advisors LLC now owns 94,008 shares of the company’s stock valued at $4,559,000 after purchasing an additional 1,220 shares during the period. Teachers Retirement System of The State of Kentucky lifted its stake in shares of Omnicell Technologies by 3.1% in the 4th quarter. Teachers Retirement System of The State of Kentucky now owns 41,456 shares of the company’s stock valued at $2,010,000 after purchasing an additional 1,233 shares during the period. California Public Employees Retirement System lifted its stake in shares of Omnicell Technologies by 1.6% in the 4th quarter. California Public Employees Retirement System now owns 87,628 shares of the company’s stock valued at $4,250,000 after purchasing an additional 1,388 shares during the period. Finally, Shelton Capital Management lifted its stake in shares of Omnicell Technologies by 17.6% in the 4th quarter. Shelton Capital Management now owns 9,800 shares of the company’s stock valued at $475,000 after purchasing an additional 1,464 shares during the period.

A number of research firms recently weighed in on OMCL. BidaskClub raised Omnicell Technologies from a “sell” rating to a “hold” rating in a research note on Saturday, May 5th. Zacks Investment Research raised Omnicell Technologies from a “sell” rating to a “hold” rating in a research note on Friday, February 2nd. Craig Hallum downgraded Omnicell Technologies from a “buy” rating to a “hold” rating in a research note on Friday, February 2nd. Cantor Fitzgerald reaffirmed a “buy” rating and set a $63.00 price target on shares of Omnicell Technologies in a research note on Thursday, February 1st. Finally, Oppenheimer reaffirmed a “buy” rating and set a $55.00 price target on shares of Omnicell Technologies in a research note on Monday, January 29th. Five research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Omnicell Technologies currently has an average rating of “Hold” and an average price target of $56.67.

In other news, Director Gary S. Petersmeyer sold 575 shares of the stock in a transaction that occurred on Thursday, March 15th. The stock was sold at an average price of $44.43, for a total value of $25,547.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman Randall A. Lipps sold 8,186 shares of the stock in a transaction that occurred on Tuesday, March 6th. The stock was sold at an average price of $44.21, for a total value of $361,903.06. Following the completion of the sale, the chairman now directly owns 224,206 shares of the company’s stock, valued at $9,912,147.26. The disclosure for this sale can be found here. Over the last three months, insiders sold 39,161 shares of company stock valued at $1,786,193. Company insiders own 3.71% of the company’s stock.

Omnicell Technologies opened at $46.20 on Friday, Marketbeat reports. Omnicell Technologies has a fifty-two week low of $39.75 and a fifty-two week high of $55.40. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.22 and a current ratio of 1.68. The company has a market cap of $1.80 billion, a P/E ratio of 256.67, a PEG ratio of 2.13 and a beta of 0.76.

Omnicell Technologies (NASDAQ:OMCL) last posted its quarterly earnings results on Thursday, April 26th. The company reported $0.29 earnings per share for the quarter, topping analysts’ consensus estimates of $0.25 by $0.04. Omnicell Technologies had a return on equity of 4.11% and a net margin of 4.55%. The business had revenue of $182.60 million for the quarter, compared to the consensus estimate of $177.49 million. During the same period in the prior year, the business earned $0.06 EPS. The firm’s revenue for the quarter was up 22.9% on a year-over-year basis. equities research analysts forecast that Omnicell Technologies will post 1.38 earnings per share for the current year.

Omnicell Technologies Profile

Omnicell, Inc provides automation and business analytics software solutions for medication and supply management in healthcare worldwide. The company operates through two segments, Automation and Analytics, and Medication Adherence. It offers Omnicell Automated Dispensing Cabinets, a dispensing system, which automates the management and dispensing of medications; SinglePointe, a software product that controls medications; AnywhereRN, a software which remotely queue medications from automated dispensing cabinets; Omnicell Analytics and Pandora Analytics reporting and data analytics tools; and Anesthesia Workstation that manages anesthesia supplies and medications.

Want to see what other hedge funds are holding OMCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omnicell Technologies (NASDAQ:OMCL).

Institutional Ownership by Quarter for Omnicell Technologies (NASDAQ:OMCL)

Receive News & Ratings for Omnicell Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell Technologies and related companies with MarketBeat.com's FREE daily email newsletter.




Leave a Reply